MedPath

山东百诺医药股份有限公司

Ownership
-
Established
2000-08-02
Employees
-
Market Cap
-
Website
http://www.bestcomm.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Zoledronic Acid Injection

Product Name
唑来膦酸注射液
Approval Number
国药准字H20253810
Approval Date
Apr 8, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253678
Approval Date
Mar 25, 2025
NMPA

Pranoprofen Eye Drops

Product Name
普拉洛芬滴眼液
Approval Number
国药准字H20253411
Approval Date
Feb 20, 2025
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20247282
Approval Date
Nov 8, 2024
NMPA

Calcium Acetate Oral Solution

Product Name
醋酸钙口服溶液
Approval Number
国药准字H20244204
Approval Date
Jun 28, 2024
NMPA

Aripiprazole Oral Solution

Product Name
阿立哌唑口服溶液
Approval Number
国药准字H20243186
Approval Date
Feb 20, 2024
NMPA

Lacosamide Oral Solution

Product Name
拉考沙胺口服溶液
Approval Number
国药准字H20234432
Approval Date
Oct 27, 2023
NMPA

Levobupivacaine Hydrochloride Injection

Product Name
盐酸左布比卡因注射液
Approval Number
国药准字H20223858
Approval Date
Apr 12, 2023
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20223128
Approval Date
Mar 16, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.